Interim (6-month) RR-TB treatment outcomes.

Figshare2016-11-04 更新2026-04-29 收录

多药耐药结核病

临床疗效中期评估

数据链接：

https://figshare.com/articles/dataset/Interim_6-month_RR-TB_treatment_outcomes_/4209246 数据链接链接失效反馈

官方服务：

资源简介：

Interim (6-month) RR-TB treatment outcomes.

创建时间：

2016-11-04

MDR-TB patients Data in the six geopolitical zones of Nigeria from January 2013 to December 2017 with treatment outcomes

多药耐药结核病

医疗健康

The aim of the study was to determine the rate of distribution, risk factors and treatment outcomes associated with multidrug-resistant tuberculosis (MDR-TB) in patients admitted to different speciali

DataCite Commons2025-04-01 更新80

BlaC E166A Cefotaxime Acyl-Intermediate Complex

多药耐药结核病

β-内酰胺酶结构生物学

BlaC E166A Cefotaxime Acyl-Intermediate Complex Descriptor: Beta-lactamase, CEFOTAXIME, C3' cleaved, ... Authors: Mire, J.A, TB Structural Genomics Consortium (TBSGC) Deposit date: 2012-03-23 Release

Protein Data Bank Japan2024-11-20 更新60

Quality assessment and sub group analysis; HIV/AIDS and multi-drug resistance tuberculosis.

传染病荟萃分析

多药耐药结核病

I2 = percentage of total variance due to between- study heterogeneity.OR = odd ratio of summary estimate.

Figshare2015-12-02 更新20

Additional file 3 of Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study

多药耐药结核病

药物敏感性

Additional file 3. Dataset of drug-susceptibility testing results.

NIAID Data Ecosystem70

Odds ratios for HIV viral suppression among PWH taking ART with a known VL at MDR-TB initiation (n = 681).